5b). Figure 5c is a representative CT scan from an AFRS patient with a bone erosion score of 22 and VD3 level of 11 ng/ml. These results support the role of VD3 in the exacerbation of CRS-associated bone erosion. In these retrospective studies we investigated circulating levels of APCs in chronic rhinosinusitis. Patients with CRSwNP and AFRS displayed elevated numbers of circulating DCs, while CRSsNP had increased numbers of macrophages. In other respiratory diseases, such as asthma, DC numbers are elevated and make a significant contribution
to disease pathogenesis, including the initiation of Th2 skewing [5,6,31]. Investigation into the potential Selleckchem AG14699 mechanism driving elevated numbers of
DCs led us to examine VD3. Both CRSwNP and AFRS patients were identified as being VD3-insufficient (<32 ng/ml) compared to control and CRSsNP. Furthermore, a strong association between VD3 deficiency and increased levels of circulating DCs in CRSwNP and AFRS was identified. Atopic status was examined as additional mechanism accounting for elevated numbers of DCs, although it was determined that there was no difference in circulating DC numbers between atopic and non-atopic BTK inhibitor research buy CRSwNP individuals. It is hypothesized that lack of VD3 allows the elevated numbers of monocytes in CRSwNP and AFRS to proceed systemically to DC differentiation and maturation more freely. While a large body of literature supports VD3 as promoting Th1 or Th2 skewing
in various disease states [33], ultimately all these demonstrate a failure of DCs to be kept in a tolerogenic state. In studies by Penna et al. it was shown that the 1,25 VD3 promoted myeloid DCs to promote a tolerogenic state [34]. The lack of the 1,25 VD3 precursor, Sitaxentan 25-OH VD3, observed in CRSwNP and AFRS may therefore allow DCs to mature with other environmental or host signals driving DCs to promote Th2 inflammation. VD3 did not correlate with all the changes in immune parameters observed in these studies. No correlation was observed between VD3 and CD14+ monocytes, suggesting that the presence of DC and macrophage precursors is not dependent upon VD3. Additionally, elevations in CD68+ macrophages did not correlate with VD3. This was not entirely unexpected, because in contrast to its inhibitory effects upon DC maturation, VD3 promotes monocyte to macrophage differentiation. Thus, patients with CRSsNP who had normal VD3 levels had higher macrophage levels than CRSwNP and AFRS patients who were VD3-insufficient. Our studies also identified that plasma levels of PGE2 and GM-CSF were up-regulated in CRSsNP and to an even greater extent in CRSwNP and AFRS. Moreover, both of these factors were found to correlate inversely with VD3 in CRSwNP and AFRS. These results are consistent with reports in asthma showing elevated PGE2[35].